Jim Chilcott BSc (Manchester), MSc (Strathclyde)

Reader in Healthcare Operational Research, Technical Director Public Health Collaborating Centre (PHCC)

Address:
HEDS, ScHARR
The University of Sheffield
Regent Court, 30 Regent Street
Sheffield S1 4DA

Tel: (+44) (0)114 222 0689
Fax: (+44) (0)114 272 4095
E-mail: j.b.chilcott@sheffield.ac.uk
Room: 2017

Biography

I gained my Mathematics degree from the University of Manchester in 1985 and my MSc in Operational Research from Strathclyde in 1986. For 10 years following the MSc I worked in Operational Research consultancy, giving practical decision support right across the health sector from hospitals to Department, in addition to the mining, banking and education sectors.

I joined ScHARR in 1996 to focus on healthcare decision support. From 2002 to 2008 I was the Technical Director of ScHARR Technology Assessment Group responsible for the scientific quality of the group's work for the NICE Technology Appraisals Programme.

I am a founding member and Technical Director of the Public Health Collaborating Centre at ScHARR.

Research interests

* Modelling in public health

* Modelling in cancer and cancer screening

* Methodological modelling interests including:

• the modelling process and errors in HTA models
• cognitive mapping for systematic reviews in complex settings
• structural uncertainty in models
• Bayesian analysis of joint disease natural history and test characteristics in screening
• value of information methods
• probabilistic sensitivity analysis methods
• meta modelling
• information gathering processes for models

Professional activities

• Member of the Operational Research Society
• Member of the Society for Social Medicine
• Member of Health Technology Assessment international (HTAi)
• Associate Editor for Journal of the Operational Research Society 2009-present
• Guest member of NHS NTA Commissioning Board 2007

Current projects

• National Institute for Health and Clinical Excellence (NICE) (2011-2012): NICE Collaborating Centre for Public Health Excellence. With E Goyder, S Paisley, R L Akehurst
• NHS Cancer Screening Programmes (2010-2011): Revisiting the options appraisal for colorectal cancer screening. With S Whyte
• UK National Screening Committee (2009-2010): Prostate Cancer Screening Options Appraisal Parts I & II. With S Hummel
• NHS Cancer Screening Programmes (2009-2010): Bowel cancer screening in England: Analysis of the FOBT referral point. With S Whyte
• National Cancer Registry of Ireland (2009-2011):Cost-effectiveness of strategies for colorectal cancer prevention in Ireland. With S Whyte and H Pilgrim
• National Institute for Health and Clinical Excellence (NICE) (2008-2011): NICE Collaborating Centre for Public Health Excellence. With E Goyder, S Paisley and R Akehurst
• NHS Cancer Screening Programme (2008-2013): Analytical support to the Bowel Cancer Screening Programme

PhD supervision

• Paul Tappenden Role and value of modelling whole disease areas. Department of Health Personal Award Scheme Fellowship (Dec 2007-Nov 2010)
• Mark Strong Methods for quantifying structural uncertainty in public health decision models. Medical Research Council Fellowship in Health Services/Public Health Research (Sep 2007 - Sep 2011)
• Hazel Squires A methodological framework for developing the structure of public health economic models. NIHR Doctoral Research Fellowship (Oct 2010 - Oct 2013)

If you are interested in studying for a PhD in any of the areas listed under my research interests above, please contact Charlotte Hollins.

Key publications

• Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review. Health Technology Assessment 2010; 14 (25). (With Tappenden P, Rawdin A, Johnson M, Kaltenthaler E, Papaioannou D, Shippam A)
• The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus-negative. British Journal of Obstetrics and Gynaecology, 2004,111:903-907 (with Tappenden P, Lloyd Jones M, Wight J, Forman K, Wray J, Beverley C) [link]
• Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. British Medical Journal, 2003,326:522-527 (with McCabe C, Tappenden P, O'Hagan T, Cooper N, Abrams K, Claxton K) [link]
• The economics of basiliximab (Simulect) in preventing acute rejection in renal transplantation. Transplant International, 2005,15:486-493 (with Holmes M, Walters S, Akehurst R, Nashan B) [link]
• Methods for expected value of information analysis in complex health economic models. Health Technology Assessment, 2004, 8:1-78 (with Tappenden P, Eggington S, Oakley J, McCabe C) [link]
• The role of modelling in planning and prioritising clinical trials. Health Technology Assessment, 2003, 7:1-144 (with Brennan A, Booth A, Karnon J, Tappenden P) [link]